FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms

Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differentially expressed genes (DEGs) between FOLFOX responders and nonresp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Lu, Wei, Fu, Dongliang, Kong, Xiangxing, Huang, Zhiheng, Hwang, Maxwell, Zhu, Yingshuang, Chen, Liubo, Jiang, Kai, Li, Xinlin, Wu, Yihua, Li, Jun, Yuan, Ying, Ding, Kefeng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013065/
https://ncbi.nlm.nih.gov/pubmed/31893575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2786
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados